4.7 Article

Ewing sarcoma gene Ews regulates hematopoietic stem cell senescence

期刊

BLOOD
卷 117, 期 4, 页码 1156-1166

出版社

AMER SOC HEMATOLOGY
DOI: 10.1182/blood-2010-04-279349

关键词

-

资金

  1. Department of Defense [W81XWH-09-1-0364]
  2. University of Pittsburgh Cancer Institute
  3. National Institutes of Health [R01HL070561]
  4. National Basic Research Program of China [2011CB964801]
  5. Tianjin International Co-operation Science Foundation [09ZC-ZDSF03800]
  6. Hillman Foundation
  7. Leukemia & Lymphoma Society
  8. National Natural Science Foundation of China (NSFC) [30825017]

向作者/读者索取更多资源

The longevity of organisms is maintained by stem cells. If an organism loses the ability to maintain a balance between quiescence and differentiation in the stem/progenitor cell compartment due to aging and/or stress, this may result in death or age-associated diseases, including cancer. Ewing sarcoma is the most lethal bone tumor in young patients and arises from primitive stem cells. Here, we demonstrated that endogenous Ewing sarcoma gene (Ews) is indispensable for stem cell quiescence, and that the ablation of Ews promotes the early onset of senescence in hematopoietic stem progenitor cells. The phenotypic and functional changes in Ews-deficient stem cells were accompanied by an increase in senescence-associated beta-galactosidase staining and a marked induction of p16(INK4a) compared with wild-type counterparts. With its relevance to cancer and possibly aging, EWS is likely to play a significant role in maintaining the functional capacity of stem cells and may provide further insight into the complexity of Ewing sarcoma in the context of stem cells. (Blood. 2011;117(4):1156-1166)

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据